Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Eris Lifesciences jumps 10% on insulin business foray

** Shares of generic drug maker  ERIS.NS  rise as much as
9.8% to 774 rupees, on track for their best one-day pct gain
since July 1 
    ** Co on Friday said https://bit.ly/3poPDHM it had formed a
joint venture with M. J. Biopharm and Kinedex Healthcare for
selling insulin 
    ** The JV will source recombinant human insulin and insulin
analogs and will market them in the domestic market - Eris
    ** Eris will hold 70% stake in the JV
    ** About 269,000 ERIS shares change hands vs the 30-day avg
volume of 98,213
    ** ERIS shares up 21.6% this year, as of last close

 (Reporting by Nallur Sethuraman in Bengaluru)
 ((Sethuraman.NR@thomsonreuters.com; (Within U.S.
1-646-223-8780, Outside U.S. +91 8067496031); Reuters Messaging:
nallur.sethuraman.thomsonreuters.com@reuters.net))

Recent news on Eris Lifesciences

See all news